Annual Total Long Term Liabilities
$40.10 M
-$58.03 M-59.13%
December 31, 2023
Summary
- As of February 20, 2025, AVDL annual total long term liabilities is $40.10 million, with the most recent change of -$58.03 million (-59.13%) on December 31, 2023.
- During the last 3 years, AVDL annual total long term liabilities has fallen by -$94.16 million (-70.13%).
- AVDL annual total long term liabilities is now -73.11% below its all-time high of $149.14 million, reached on December 31, 2018.
Performance
AVDL Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$40.81 M
-$1.81 M-4.25%
September 30, 2024
Summary
- As of February 20, 2025, AVDL quarterly total long term liabilities is $40.81 million, with the most recent change of -$1.81 million (-4.25%) on September 30, 2024.
- Over the past year, AVDL quarterly long term liabilities has increased by +$703.00 thousand (+1.75%).
- AVDL quarterly long term liabilities is now -77.03% below its all-time high of $177.62 million, reached on March 31, 2018.
Performance
AVDL Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
AVDL Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -59.1% | +1.8% |
| 3 y3 years | -70.1% | +549.6% |
| 5 y5 years | -73.1% | +549.6% |
AVDL Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -72.9% | at low | -72.4% | +549.6% |
| 5 y | 5-year | -72.9% | at low | -72.4% | +549.6% |
| alltime | all time | -73.1% | +1905.2% | -77.0% | +2167.1% |
Avadel Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $40.81 M(-4.3%) |
| Jun 2024 | - | $42.62 M(+2.2%) |
| Mar 2024 | - | $41.71 M(+4.0%) |
| Dec 2023 | $40.10 M(-59.1%) | $40.10 M(+3.1%) |
| Sep 2023 | - | $38.90 M(+519.2%) |
| Jun 2023 | - | $6.28 M(-93.7%) |
| Mar 2023 | - | $99.54 M(+1.4%) |
| Dec 2022 | $98.14 M(-33.7%) | $98.14 M(-15.9%) |
| Sep 2022 | - | $116.69 M(+1.4%) |
| Jun 2022 | - | $115.05 M(-5.6%) |
| Mar 2022 | - | $121.87 M(-17.7%) |
| Dec 2021 | $148.02 M(+10.2%) | $148.02 M(+0.3%) |
| Sep 2021 | - | $147.54 M(+0.1%) |
| Jun 2021 | - | $147.43 M(+0.1%) |
| Mar 2021 | - | $147.32 M(+9.7%) |
| Dec 2020 | $134.26 M(-7.2%) | $134.26 M(+0.6%) |
| Sep 2020 | - | $133.43 M(+0.9%) |
| Jun 2020 | - | $132.26 M(-7.7%) |
| Mar 2020 | - | $143.32 M(-0.9%) |
| Dec 2019 | $144.65 M(-3.0%) | $144.65 M(-4.3%) |
| Sep 2019 | - | $151.09 M(+0.8%) |
| Jun 2019 | - | $149.91 M(-1.3%) |
| Mar 2019 | - | $151.85 M(+1.8%) |
| Dec 2018 | $149.14 M(+83.8%) | $149.14 M(-4.5%) |
| Sep 2018 | - | $156.25 M(-5.4%) |
| Jun 2018 | - | $165.08 M(-7.1%) |
| Mar 2018 | - | $177.62 M(+118.9%) |
| Dec 2017 | $81.16 M(-42.4%) | $81.16 M(-3.0%) |
| Sep 2017 | - | $83.66 M(-10.7%) |
| Jun 2017 | - | $93.72 M(-18.9%) |
| Mar 2017 | - | $115.56 M(-18.0%) |
| Dec 2016 | $140.99 M(+40.0%) | $140.99 M(-7.2%) |
| Sep 2016 | - | $151.97 M(+8.8%) |
| Jun 2016 | - | $139.68 M(+12.3%) |
| Mar 2016 | - | $124.37 M(+23.5%) |
| Dec 2015 | $100.70 M(+28.3%) | $100.70 M(-16.2%) |
| Jun 2015 | - | $120.16 M(+38.9%) |
| Mar 2015 | - | $86.51 M(+10.3%) |
| Dec 2014 | $78.47 M(-7.9%) | $78.47 M(+2.4%) |
| Sep 2014 | - | $76.62 M(-2.9%) |
| Jun 2014 | - | $78.93 M(+19.0%) |
| Mar 2014 | - | $66.32 M(-22.1%) |
| Dec 2013 | $85.17 M(+17.6%) | $85.17 M(-13.4%) |
| Sep 2013 | - | $98.31 M(-11.7%) |
| Jun 2013 | - | $111.37 M(+27.2%) |
| Mar 2013 | - | $87.53 M(+20.8%) |
| Dec 2012 | $72.45 M | $72.45 M(-21.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $92.11 M(+4.4%) |
| Mar 2012 | - | $88.25 M(+314.4%) |
| Dec 2011 | $21.29 M(+12.7%) | $21.29 M(-6.2%) |
| Sep 2011 | - | $22.69 M(-10.3%) |
| Jun 2011 | - | $25.31 M(+44.6%) |
| Mar 2011 | - | $17.50 M(-7.3%) |
| Dec 2010 | $18.89 M(-28.8%) | $18.89 M(-3.4%) |
| Sep 2010 | - | $19.55 M(-0.4%) |
| Jun 2010 | - | $19.64 M(-10.1%) |
| Mar 2010 | - | $21.85 M(-17.7%) |
| Dec 2009 | $26.54 M(+15.1%) | $26.54 M(+0.6%) |
| Sep 2009 | - | $26.37 M(-2.7%) |
| Jun 2009 | - | $27.10 M(+19.5%) |
| Mar 2009 | - | $22.68 M(-1.7%) |
| Dec 2008 | $23.06 M(+5.7%) | $23.06 M(+17.9%) |
| Sep 2008 | - | $19.56 M(-10.8%) |
| Jun 2008 | - | $21.93 M(-1.5%) |
| Mar 2008 | - | $22.26 M(+2.0%) |
| Dec 2007 | $21.82 M(+6.2%) | $21.82 M(+1.7%) |
| Sep 2007 | - | $21.45 M(-4.3%) |
| Jun 2007 | - | $22.43 M(+8.3%) |
| Mar 2007 | - | $20.70 M(+0.7%) |
| Dec 2006 | $20.55 M(+60.6%) | $20.55 M(+6.3%) |
| Sep 2006 | - | $19.33 M(+28.8%) |
| Jun 2006 | - | $15.01 M(+11.5%) |
| Mar 2006 | - | $13.46 M(+5.1%) |
| Dec 2005 | $12.80 M(+131.7%) | $12.80 M(+7.9%) |
| Sep 2005 | - | $11.87 M(+69.8%) |
| Jun 2005 | - | $6.99 M(+26.0%) |
| Mar 2005 | - | $5.55 M(+0.4%) |
| Dec 2004 | $5.53 M(-68.1%) | $5.53 M(-55.7%) |
| Sep 2004 | - | $12.48 M(0.0%) |
| Jun 2004 | - | $12.48 M(-12.2%) |
| Mar 2004 | - | $14.21 M(-18.0%) |
| Dec 2003 | $17.32 M(+304.6%) | $17.32 M(+270.5%) |
| Sep 2003 | - | $4.67 M(-13.7%) |
| Jun 2003 | - | $5.42 M(+1.3%) |
| Mar 2003 | - | $5.35 M(+25.0%) |
| Dec 2002 | $4.28 M(+2.6%) | $4.28 M(+1.8%) |
| Sep 2002 | - | $4.21 M(+0.8%) |
| Dec 2001 | $4.17 M(+24.0%) | $4.17 M(+24.0%) |
| Dec 2000 | $3.37 M(+42.7%) | $3.37 M(+42.7%) |
| Dec 1999 | $2.36 M(-25.8%) | $2.36 M(-25.8%) |
| Dec 1998 | $3.18 M(+2.6%) | $3.18 M(+6.0%) |
| Mar 1998 | - | $3.00 M(-3.2%) |
| Dec 1997 | $3.10 M(+55.0%) | $3.10 M(+55.0%) |
| Dec 1996 | $2.00 M | $2.00 M(+11.1%) |
| Mar 1996 | - | $1.80 M |
FAQ
- What is Avadel Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Avadel Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Avadel Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of AVDL is $40.10 M
What is the all time high annual total long term liabilities for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high annual total long term liabilities is $149.14 M
What is Avadel Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, AVDL annual total long term liabilities has changed by -$58.03 M (-59.13%)
What is Avadel Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of AVDL is $40.81 M
What is the all time high quarterly long term liabilities for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high quarterly total long term liabilities is $177.62 M
What is Avadel Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, AVDL quarterly total long term liabilities has changed by +$703.00 K (+1.75%)